Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (TSXV:NSP, OTC:NSPDF, FRANKFURT:50N), a healthy food, hemp product developer and largescale producer for inhouse brands as well as global contract manufacturer, is pleased to provide insight in regard to strategic positioning in the evolving cannabinoid extract, edibles markets.

Naturally Splendid’s strategy to manufacture its own company branded products and provide existing and new contract manufacturing services for private label clients is anticipated to include cannabinoid extraction and/or edible products once the pending regulatory framework is defined and necessary licenses have been secured. With a collective of over a decade of experience in hemp and food manufacturing, combined with recently achieved Safe Quality Food Level 2 Certification (SQF2) at its Pitt Meadows manufacturing facility. Naturally Splendid has gained invaluable experience and knowledge in this area, which will be a valuable asset in developing relationships with higher tier food service clients.

In the 10 years since its inception, the Company has worked hard to build shareholder value through an overlying strategy of manufacturing nutritional company branded products under such brand names as; Natera Sport(TM); Natera Hemp Foods(TM); Chii Hemp Foods; Elevate Me(TM) Nutritional Bars; and PawsitiveFX(TM), as well as offering contract manufacturing services producing private label products for a wide range of national and international clients.

Naturally Splendid’s Natera Sport(TM) brand, launched in late 2018, has already earned a favourable reputation as a superior source of natural, sports nutrition. The brand is well positioned to benefit from the increasing consumer demand for plant-based and all-natural products. Company CEO Mr. J. Craig Goodwin states, “The popularity of our established products allows us to enter the sports nutrition space with a strong and growing brand as we continue towards a regulated market of sport and food products that will be allowed to contain cannabinoids such as CBD (cannabidiol). We view the adoption of CBD in future Natera Sport(TM) offerings as a potentially significant growth driver for our business”.

In this regard, the Company has entered the sports nutrition market through its Natera Sport(TM) Bites that are suitable for every level of athlete from weekend warriors to elite athletes, including becoming popular with many professional golfers on the PGA Tour. Natera Sport(TM) Bites appeared in the August 2019 and October 2019 editions of Golf Magazine, a magazine with a monthly following in excess of 15,000,000 readers, as a preferred nutritional product of many professional golfers.

Naturally Splendid Vice President Mr. Bryan Carson states, “This is another historic day in the evolution of the evolving hemp and cannabinoid markets in Canada. The new regulations covering Cannabis Health Products (CHPs) as set forth under Health Canada’s “Cannabis Act”, will allow for systematic approvals of cannabinoid infused products for public consumption. It is anticipated that, initially, approved products will be somewhat limited and that many of these products will not be available until December 2019. This works in our favour as Naturally Splendid has a thriving nutritional bars and bites operation that is not dependent nor impeded by the new regulations whatsoever. Yet the Company is ideally positioned as these CBD products become more mainstream and appropriate licensing is obtained”.

Natera Sport(TM) Bites were formulated by Dr. Stuart Love, a health practitioner in his eleventh year on the PGA Tour. Dr. Love states, “This lays the groundwork for the adoption of cannabidiol (“CBD”) in future product offerings in accordance with regulations. I very much look forward to the evolution of Natera Sport(TM) Bites and to offering products infused with CBD as these regulations evolve globally”. Dr. Love adds, “The use and acceptance of CBD-based products in the professional sports landscape has changed. We have witnessed the negative effects of prescription painkillers, and athletes are looking for healthier alternatives. We believe CBD to be one of those healthier alternatives that will augment our already nutrient dense product offerings.” Dr. Stuart Love is the formulator of Natera Sport(TM) Bites and a Company Advisor to Naturally Splendid.

‘Cross-over opportunities’ are abundant, as established nutrition companies are venturing into the cannabinoid infused space and licensed producers or processing companies are venturing into more traditional markets. Most recently, Canopy Growth acquired a 72% stake in sports nutrition and hydration company, BioSteel. According to Canopy, this acquisition will further expand its potential CBD (cannabidiol) offerings. This is a strategy shared by Naturally Splendid through its established Natera Sport(TM) line. Natera Sport(TM) KEY-TO-LIFE keto bars are now found in over 2,000 retailers across Canada.

“In short”, states Company COO, Mr. Barry Dashner, “We have a thriving nutritional bar business in traditional distribution channels that continues to grow sales quarter after quarter which is unrestricted under the new edible regulations that will soon be in play. The progression at our facility from manufacturing conventional food to infused food will be a seamless transition, as NSE has already installed and is operating specialized equipment that allows for several different infusion and coating methods. This has created increased capacity at our facility, which has already led to additional business for NSE prior to infused regulations coming into effect. We believe our manufacturing division is well positioned to capitalize on the upcoming legalization of edibles and food production in Canada, and in fact abroad. ”

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient-dense foods, and related products. Naturally Splendid is focused on the commercial uses of industrial hemp, and once regulations allow, in permitting jurisdictions, this will include CBD (cannabidiol), and other cannabinoid compounds in a broad spectrum of applications.

For more information e-mail or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Craig Goodwin

CEO, President, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax: (604) 465-1128



Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.


Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation.


Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less